Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview

Maravai Lifesciences Holdings

12/03/2025 20:06

Maravai LifeSciences Holdings Inc MRVI.OQ MRVI.O is expected to show a fall in quarterly revenue when it reports  results on March 14 (estimated) for the period ending December 31 2024

The San Diego California-based  company is expected to report a 22.7% decrease in revenue to $57.345 million from $74.14 million a year ago, according to the mean estimate from 14 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Maravai LifeSciences Holdings Inc is for a loss of 4 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Maravai LifeSciences Holdings Inc is $9.25​, above​ its last closing price of $2.64. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.01
-0.01
-0.02
Missed
-160.1
Jun. 30 2024
0.00
0.00
0.00
Met
-100
Mar. 31 2024
-0.03
-0.03
-0.02
Beat
21.4​
Dec. 31 2023
-0.01
-0.01
0.01
Beat
184.6
​​Sep. 30 2023
0.00
0.01
-0.01
Missed
-257.2
Jun. 30 2023
0.01
0.01
0.00
Missed
-100​
Mar. 31 2023
0.04
0.04
0.03
Missed
-17.2
Dec. 31 2022
0.35
0.34
0.35
Beat
2.4

This summary was machine generated March 12 at 20:06 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)